Mitotane 相關新聞

← 返回新聞總覽


Mitotane 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Mitotane 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma. The effect of Lysodren on non-functional adrenal cortical carcinoma is not established.
  • 證據等級:L5
  • 預測適應症(20 個):
    • multiple endocrine neoplasia(98.0%)
    • acne (disease)(97.8%)
    • breast fibrocystic disease(93.8%)
    • benign mammary dysplasia(93.0%)
    • seborrheic keratosis(93.0%)
    • vulvar inverted follicular keratosis(92.7%)
    • apocrine adenosis of breast(91.8%)
    • blunt duct adenosis of breast(91.8%)
    • fat necrosis of breast(90.2%)
    • breast abscess(90.2%)
    • motor nerve neuritis(89.4%)
    • vestibular neuronitis(89.3%)
    • brachial plexus neuritis(89.0%)
    • lactation disease(88.4%)
    • neuroretinitis(85.5%)
    • breast adenosis(85.0%)
    • familial pityriasis rubra pilaris(81.6%)
    • candidiasis(81.5%)
    • inherited cutis laxa(79.1%)
    • alkaptonuria(77.9%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.